Evidence map›Paper›PMID 29897791›Full record

ArticleAmerican journal of respiratory and critical care medicine2018

Macrophage Rac2 Is Required to Reduce the Severity of Cigarette Smoke-induced Pneumonia.

Jennifer L Larson-Casey, Linlin Gu, Patricia L Jackson, David E Briles, Joanetha Y Hale, J Edwin Blalock, J Michael Wells, Jessy S Deshane, Yong Wang, Dana Davis and 4 more

Open access · greenAbstract read
In one paragraph

Article in American journal of respiratory and critical care medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. C-rac-king the Code of Smoke-induced Pneumonia Susceptibility.American journal of respiratory and critical care medicine · 2018
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Jennifer L Larson-Casey1 Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine.ORCID 0000-0001-7238-7986
Linlin Gu1 Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine.
Patricia L Jackson1 Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine.
David E Briles3 Department of Microbiology, and.
Joanetha Y Hale3 Department of Microbiology, and.
J Edwin Blalock1 Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine.
J Michael Wells1 Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine.
Jessy S Deshane1 Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine.
Yong Wang1 Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine.
Dana Davis1 Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine.
Veena B Antony1 Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine.
Adriana V F Massicano4 Department of Radiology, University of Alabama at Birmingham, Birmingham, Alabama; and.
Suzanne E Lapi4 Department of Radiology, University of Alabama at Birmingham, Birmingham, Alabama; and.
A Brent Carter1 Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine.ORCID 0000-0001-6002-4715
Pulmonary and Allergy Associates · USBirmingham VA Medical Center · USUniversity of Alabama at Birmingham · US

Funding

UAB Neuroscience Core CenterP30NS047466 · NINDS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI WYSS, J. MICHAEL · 2005 to 2019
$8.5M
A Novel Exosomal Inflammatory PathwayR35HL135710 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BLALOCK, J EDWIN · 2017 to 2023
$6.8M
Lung Macrophage Metabolic Reprogramming in Asbestos-Induced ToxicityR01ES015981 · NIEHS · UNIVERSITY OF IOWA · PI CARTER, A BRENT · 2007 to 2022
$5.5M
HL-A New Pathway for Neutrophil-induced Airway InflammationR01HL077783 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BLALOCK, J EDWIN · 2006 to 2016
$3.2M
Environmental Cadmium and COPDR01ES029981 · NIEHS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI ANTONY, VEENA B. · 2018 to 2022
$2.5M
Acquired LTA4H Dysfunction in COPDR01HL110950 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BLALOCK, J EDWIN · 2012 to 2015
$2.0M
Vaccine potential of the proline-rich domain of pneumococcal surface protein AR01AI118805 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BRILES, DAVID E · 2015 to 2019
$1.8M
Myeloid-Derived Regulatory Cells in AsthmaR01HL128502 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI DESHANE, JESSY SATYADAS · 2016 to 2020
$1.8M
Genetics of Smoke-Altered LTA4H in COPDR01HL126596 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BLALOCK, J EDWIN, CASTALDI, PETER · 2015 to 2018
$1.6M
PGP, A Possible Biomarker for COPD Exacerbations and or ProgressionR01HL114439 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BLALOCK, J EDWIN · 2012 to 2015
$1.5M
The Role of PGP in COPD-associated Pulmonary HypertensionK08HL123940 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI WELLS, JAMES MICHAEL · 2014 to 2018
$744k
Asbestos toxicity is modulated by MCU-mediated macrophage apoptosis resistanceR56ES027464 · NIEHS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI CARTER, A BRENT · 2017 to 2017
$150k
NHLBI NIH HHS K08 HL123940NHLBI NIH HHS R01 HL077783NHLBI NIH HHS R01 HL110950NHLBI NIH HHS R01 HL114439NHLBI NIH HHS R01 HL126596NHLBI NIH HHS R01 HL128502NHLBI NIH HHS R35 HL135710NIAID NIH HHS R01 AI118805NIEHS NIH HHS R01 ES015981NIEHS NIH HHS R01 ES029981NIEHS NIH HHS R56 ES027464NINDS NIH HHS P30 NS047466
6 · The paper itself

Abstract

rationaleCigarette smoking is prevalent in the United States and is the leading cause of preventable diseases. A prominent complication of smoking is an increase in lower respiratory tract infections (LRTIs). Although LRTIs are known to be increased in subjects that smoke, the mechanism(s) by which this occurs is poorly understood.

objectivesDetermine how cigarette smoke (CS) reduces reactive oxygen species (ROS) production by the phagocytic NOX2 (NADPH oxidase 2), which is essential for innate immunity in lung macrophages.

methodsNOX2-derived ROS and Rac2 (Ras-related C3 botulinum toxin substrate 2) activity were determined in BAL cells from wild-type and Rac2 MEASUREMENTS AND MAIN

resultsNOX2-derived ROS in BAL cells was reduced in mice exposed to CS via inhibition of the small GTPase Rac2. These mice had greater bacterial burden and increased mortality compared with air-exposed mice. BAL fluid from CS-exposed mice had increased levels of cadmium, which mediated the effect on Rac2. Similar observations were seen in human subjects that smoke. To support the importance of Rac2 in the macrophage immune response, overexpression of constitutively active Rac2 by lentiviral administration increased NOX2-derived ROS, decreased bacterial burden in lung tissue, and increased survival compared with CS-exposed control mice.

conclusionsThese observations suggest that therapies to maintain Rac2 activity in lung macrophages restore host defense against respiratory pathogens and diminish the prevalence of LRTIs in subjects that smoke.

Indexed as

AnimalsCigarette SmokingDisease Models, AnimalFemaleHumansImmunity, InnateLungMacrophagesMaleMiceMice, Inbred C57BLMiddle AgedPneumoniaRAC2 GTP-Binding Proteinrac GTP-Binding ProteinsReactive Oxygen SpeciesRAC2 GTP-Binding Proteinrac GTP-Binding ProteinsReactive Oxygen Speciesheavy metalsinnate immunityNADPH oxidase 2respiratory tract infections

Identifiers

PMID29897791
PMCPMC6290940
OpenAlexW2808553989

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.